Undisclosed CRC Program(s)

About Indivumed Therapeutics

Indivumed Therapeutics is a Hamburg-based oncology biotech with a vertically integrated platform built on a proprietary, clinically annotated biobank and multi-omics database. The company's core strength is its 20+ year collection of pre-analytically controlled human tumor samples paired with comprehensive clinical data, which it analyzes with AI and biomathematical tools to identify and validate novel therapeutic targets. Indivumed is advancing a pipeline of first-in-class candidates, initially focused on colorectal cancer (CRC), and offers partnership opportunities leveraging its unique data and discovery engine. It operates as a private, likely pre-revenue entity, progressing programs from discovery toward clinical development.

Therapeutic Areas

Other Colorectal Cancer Drugs